PAB is a great little company and the fundamentals appear stronger than they have been previously however its a slow and frustrating process to get to where we all want it to be.
After holding PAB for over 7 years it is clear that a sustained SP rise is only possible once we reach clinical trials (with positive results) or we have some form of partnering or interest from major pharma to re-rate the stock. The other alternative may be a takeover but I doubt that would happen. Until then I wouldn't be surprised to see it drift toward 1 cent which is a good thing for those who believe and want to top up their coffers.
PAB is a great little company and the fundamentals appear...
-
- There are more pages in this discussion • 1,121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $2.505K | 375.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 4356781 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2239285 | 4 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |